Benzinga's Top Initiations By: Benzinga via Benzinga September 22, 2015 at 09:00 AM EDT Analysts at Barclays initiated coverage on ISIS Pharmaceuticals, Inc. (NASDAQ: ISIS) with a Equal-weight rating. The target price for ... Read More >> Related Stocks: CenturyLink Conatus Pharmaceutic Golar Lng Partners Halozyme Therapeutic Middlefield Banc Zendesk Inc